デフォルト表紙
市場調査レポート
商品コード
1405834

マイクロRNAの市場規模、シェア、動向分析レポート:製品・サービス別、最終用途別、地域別、セグメント別予測、2024年~2030年

MicroRNA Market Size, Share & Trends Analysis Report By Products & Services (Instruments, Consumables), By Application (Cancer, Infectious Diseases) By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
マイクロRNAの市場規模、シェア、動向分析レポート:製品・サービス別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2023年12月11日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マイクロRNA市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のマイクロRNAの市場規模は、2024年から2030年にかけて12.87%のCAGRを記録し、2030年までには36億4,000万米ドルに達すると予測されています。

市場の開拓は、臨床試験におけるマイクロRNAの統合の成功と相まって、新規診断検査や治療薬の開発のための研究開発イニシアティブへの多額の投資によって推進されています。現在のバイオテクノロジー産業において、バイオ医薬品部門は重要な役割を果たしています。バイオテクノロジー業界では、研究開発への支出が大幅に増加しています。いくつかのバイオ医薬品会社は、RNAベースの治療薬(miRNAとsiRNA)の開発に投資しています。主な企業には、Regulus Therapeutics、Rosetta Genomics、Alnylam Pharmaceuticals、miRagen Therapeutics、Mirna Therapeuticsなどがあります。

新たな診断検査や治療薬の開発のためのmiRNA研究開発に対する政府資金の増加と相まって、多額の投資が市場の成長を後押しすると予想されています。標的治療薬の開発や創薬ターゲットの同定のための革新的なアプローチで市場に参入してきた新規参入企業もいくつかあります。例えば、2022年4月にElsevierに掲載された論文では、研究チームが疾患の早期診断のための循環miRNAの臨床的価値を示す現在の大規模コホート研究の概要を提供しています。

特に胸部がんのようながん細胞株において、様々なマイクロRNAの腫瘍抑制効果を調査する研究が増加していることが、マイクロRNA研究ツールに対する需要の増加を促しています。さらに、miRNAベースの治療薬は様々な疾患の治療において高い可能性を示しており、絶えず進化を続けています。miRNAベースの治療薬を標的細胞に正確に送達することは、臨床応用のための大きな課題として残っています。しかし、ナノ粒子ベースの送達システムなど、効率的な送達システムの最近の導入が、この課題の克服に役立つと期待されています。

マイクロRNA市場レポートハイライト

  • 製品・サービス別では、単離・精製、miRNA cDNA合成、プロファイリング、局在化、定量化、機能解析など幅広いサービスを提供できるサービス分野が、2023年に58.8%の最高収益シェアで市場を独占しました。
  • 用途別では、miRNAシグネチャーを採用するがん研究への投資が多いことから、がん分野が2023年に最も高い収益シェアを占めました。
  • 最終用途別では、バイオテクノロジー・製薬企業セグメントが2023年に最も高い収益シェアで市場を独占しています。これは、最先端の研究へのアクセスや大規模プロジェクトでの共同研究を可能にする研究機関との共同研究やパートナーシップを確立する能力があるためです。
  • 北米は、同地域に主要な市場プレーヤーが存在するため、2023年に世界の業界を支配しました。

目次

第1章 調査手法と範囲

第2章 マイクロRNA(miRNA)市場:エグゼクティブサマリー

  • 市場スナップショット
  • 製品とサービスのスナップショット
  • アプリケーションと最終用途のスナップショット
  • 競合情勢のスナップショット

第3章 マイクロRNA(miRNA)市場変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
  • 市場促進要因分析
    • COVID-19の発生
    • miRNA応用における最近の技術革新
    • 新しい診断検査と治療法の開発のためのmiRNA研究開発イニシアチブへの多額の投資
    • 臨床試験におけるmiRNAの成功
    • 核酸研究を支える技術の進歩
    • シーケンスのコストが指数関数的に減少
  • 市場抑制要因分析
    • マイクロRNAキットやその他の製品に関連する高コスト
    • RNAの取り扱いとマイクロRNA検出用アッセイの社内開発における課題
    • 調査の再現性や製品の特異性が低い
    • 新興市場における限られたライフサイエンス調査インフラ
  • 事業環境分析
    • ポーターのファイブフォース分析
    • PESTLE分析
  • COVID-19の分析

第4章 製品とサービスの推定・動向分析

  • マイクロRNA(miRNA)市場:製品変動分析
  • 機器
    • 機器市場推計・予測、2018年~2030年
    • テクノロジー
    • ワークフロー
  • 消耗品
    • 消耗品市場推計・予測、2018年~2030年
    • 検体
    • ワークフロー
  • サービス
    • サービスタイプの市場推計・予測、2018年~2030年
    • 分離と精製
    • miRNA cDNA合成
    • プロファイリング、ローカリゼーション、認定
    • 機能的解析
    • その他
  • 検体
    • 検体市場推計・予測、2018年~2030年
    • 全血
    • 血清
    • プラズマ
    • FFPE
    • 新鮮な冷凍組織
    • その他

第5章 アプリケーションの推定・動向分析

  • マイクロRNA(miRNA)市場:アプリケーションの変動分析
  • がん
    • がん市場収益推計と予測、2018年~2030年
  • 感染症
    • 感染症市場収益推計と予測、2018年~2030年
  • 免疫疾患
    • 免疫疾患市場収益推計と予測、2018年~2030年
  • 循環器疾患
    • 循環器疾患市場収益推計と予測、2018年~2030年
  • 神経疾患
    • 神経疾患市場収益推計と予測、2018年~2030年
  • その他
    • その他の市場収益推計と予測、2018年~2030年

第6章 最終用途推定・動向分析

  • マイクロRNA(miRNA)市場:最終用途の変動分析
  • バイオテクノロジー・製薬会社
    • バイオテクノロジー・製薬企業市場収益推計と予測、2018年~2030年
  • 学術および政府調査機関
    • 学術および政府調査機関の市場収益推計と予測、2018年~2030年
  • その他のエンドユーザー
    • その他のエンドユーザー市場収益推計と予測、2018年~2030年

第7章 地域ビジネス分析

  • 地域市場のスナップショット
  • 北米
    • 北米のマイクロRNA
    • 米国
    • カナダ
  • 欧州
    • 欧州のマイクロRNA
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋のマイクロRNA
    • 日本
    • 中国
    • インド
    • 韓国
    • タイ
    • オーストラリア
  • ラテンアメリカ
    • ラテンアメリカのマイクロRNA
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカのマイクロRNA
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
    • 取得
    • 製品/サービスの開始
    • パートナーシップ/コラボレーション
    • その他
  • 市況分析、2023年
  • 企業プロファイル
    • Thermo Fisher Scientififc, Inc
    • QIAGEN
    • Horizon Discovery Group Co.
    • NanoString Technologies, Inc
    • Merck KGaA
    • Takara Bio, Inc
    • LGC Limited
    • BioGenex
    • GeneCopoeia, Inc
    • New England Biolabs
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 4 Global MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 6 Global MicroRNA Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 9 North America MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 10 North America MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 11 U.S. MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 12 U.S. MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 14 Canada MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 15 Canada MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 Canada MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 17 Europe MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 19 Europe MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Europe MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 21 Germany MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 22 Germany MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Germany MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 24 UK MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 25 UK MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 26 UK MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 27 France MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 28 France MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 France MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 30 Italy MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 31 Italy MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 Italy MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 33 Spain MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 34 Spain MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 35 Spain MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 36 Denmark MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 37 Denmark MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 38 Denmark MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 39 Norway MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 40 Norway MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 Norway MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 42 Sweden MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 43 Sweden MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 50 China MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 51 China MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 China MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 53 Japan MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 54 Japan MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Japan MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 56 India MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 57 India MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 India MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 59 South Korea MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 60 South Korea MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 South Korea MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 62 Australia MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 63 Australia MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 64 Australia MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 65 Thailand MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 66 Thailand MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 67 Thailand MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 68 Latin America MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 69 Latin America MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Latin America MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 71 Brazil MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 72 Brazil MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Brazil MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 74 Mexico MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 75 Mexico MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 76 Mexico MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 77 Argentina MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 78 Argentina MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 84 South Africa MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 85 South Africa MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 90 UAE MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 91 UAE MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 92 UAE MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 93 Kuwait MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 94 Kuwait MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait MicroRNA Market, End-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Mineral Supplements, Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2023
  • Fig. 15 Global MicroRNA Market: Products & Services Movement Analysis
  • Fig. 16 Global MicroRNA Market, for Products, 2018 - 2030 (USD Million)
  • Fig. 17 Global MicroRNA Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 18 Global MicroRNA Market, for Technology, 2018 - 2030 (USD Million)
  • Fig. 19 Global MicroRNA Market, for Real-Time PCR, 2018 - 2030 (USD Million)
  • Fig. 20 Global MicroRNA Market, for Microarray, 2018 - 2030 (USD Million)
  • Fig. 21 Global MicroRNA Market, for NGS, 2018 - 2030 (USD Million)
  • Fig. 22 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 23 Global MicroRNA Market, for Workflow, 2018 - 2030 (USD Million)
  • Fig. 24 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
  • Fig. 25 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 26 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
  • Fig. 27 Global MicroRNA Market, for Functional Analysis & Others, 2018 - 2030 (USD Million)
  • Fig. 28 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 Global MicroRNA Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 30 Global MicroRNA Market, for Specimen, 2018 - 2030 (USD Million)
  • Fig. 31 Global MicroRNA Market, for Whole Blood, 2018 - 2030 (USD Million)
  • Fig. 32 Global MicroRNA Market, for Serum, 2018 - 2030 (USD Million)
  • Fig. 33 Global MicroRNA Market, for Plasma, 2018 - 2030 (USD Million)
  • Fig. 34 Global MicroRNA Market, for FFPE, 2018 - 2030 (USD Million)
  • Fig. 35 Global MicroRNA Market, for Fresh Frozen Tissue, 2018 - 2030 (USD Million)
  • Fig. 36 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 37 Global MicroRNA Market, for Workflow, 2018 - 2030 (USD Million)
  • Fig. 38 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
  • Fig. 39 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 40 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
  • Fig. 41 Global MicroRNA Market, for Functional Analysis, 2018 - 2030 (USD Million)
  • Fig. 42 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 43 Global MicroRNA Market, for Services, 2018 - 2030 (USD Million)
  • Fig. 44 Global MicroRNA Market, for Type, 2018 - 2030 (USD Million)
  • Fig. 45 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
  • Fig. 46 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 47 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
  • Fig. 48 Global MicroRNA Market, for Functional Analysis, 2018 - 2030 (USD Million)
  • Fig. 49 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 50 Global MicroRNA Market, for Specimen, 2018 - 2030 (USD Million)
  • Fig. 51 Global MicroRNA Market, for Whole Blood, 2018 - 2030 (USD Million)
  • Fig. 52 Global MicroRNA Market, for Serum, 2018 - 2030 (USD Million)
  • Fig. 53 Global MicroRNA Market, for Plasma, 2018 - 2030 (USD Million)
  • Fig. 54 Global MicroRNA Market, for FFPE, 2018 - 2030 (USD Million)
  • Fig. 55 Global MicroRNA Market, for Fresh Frozen Tissue, 2018 - 2030 (USD Million)
  • Fig. 56 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 57 Global MicroRNA Market: Application Movement Analysis
  • Fig. 58 Global MicroRNA Market, for Cancer, 2018 - 2030 (USD Million)
  • Fig. 59 Global MicroRNA Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 60 Global MicroRNA Market, for Immunological Disorder, 2018 - 2030 (USD Million)
  • Fig. 61 Global MicroRNA Market, for cardiovascular disease, 2018 - 2030 (USD Million)
  • Fig. 62 Global MicroRNA Market, for Neurological Disease, 2018 - 2030 (USD Million)
  • Fig. 63 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 64 Global MicroRNA Market: End-Use Movement Analysis
  • Fig. 65 Global MicroRNA Market, for Biotechnology & Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 66 Global MicroRNA Market, for Academic & Government Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 67 Global MicroRNA Market, for Other end-users, 2018 - 2030 (USD Million)
  • Fig. 68 Regional Marketplace: Key Takeaways
  • Fig. 69 Regional Outlook, 2022 & 2030
  • Fig. 70 Global MicroRNA Market: Region Movement Analysis
  • Fig. 71 North America MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 72 U.S. MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 73 Canada MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 74 Europe MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 75 Germany MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 76 UK MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 77 France MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 78 Italy MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 79 Spain MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 80 Denmark MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 81 Norway MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 82 Sweden MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 83 Asia Pacific MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 84 Japan MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 85 China MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 86 India MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 87 Thailand MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 88 Australia MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 89 South Korea MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 90 Latin America MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 91 Brazil MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 92 Mexico MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 93 Argentina MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 94 Middle East and Africa MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 95 South Africa MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 96 Saudi Arabia MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 97 UAE MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 98 Kuwait MicroRNA Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-368-3

MicroRNA Market Growth & Trends:

The global microRNA market size is expected to reach USD 3.64 billion by 2030, registering a CAGR of 12.87% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is propelled by substantial investments in research and development initiatives for the development of novel diagnostic tests and therapeutics, coupled with the successful integration of microRNAs in clinical trials. The biopharmaceutical sector plays a significant role in the current biotechnology industry. The expenditure on R&D has significantly increased in the biotechnology industry. Several biopharmaceutical companies are investing in the development of RNA-based therapeutics (miRNAs & siRNAs). Some of the major players are Regulus Therapeutics, Rosetta Genomics, Alnylam Pharmaceuticals, miRagen Therapeutics, and Mirna Therapeutics.

The substantial investments coupled with increased government funding in miRNA R&D initiatives for the development of new diagnostic tests & therapeutics are anticipated to boost the market growth. Several new players have arrived in the market with innovative approaches for the development of targeted therapeutics and identifying drug targets. For instance, in an article published in Elsevier in April 2022, a team of researchers provided a summary of current large-cohort studies that show the clinical value of circulating miRNAs for the early diagnosis of disease.

The rising number of studies investigating the tumor-suppressive effects of various microRNAs, particularly in cancer cell lines like thoracic cancer, is driving an increased demand for microRNA research tools. Additionally, miRNA-based therapeutics have demonstrated high potential in the treatment of various diseases and are continuously evolving. Accurate delivery of miRNA-based therapeutic agents to the targeted cells remains a major challenge for clinical applications. However, the recent introduction of efficient delivery systems, such as nanoparticle-based delivery systems, is anticipated to help overcome this challenge.

MicroRNA Market Report Highlights:

  • Based on products & services, the services segment dominated the market with the highest revenue share of 58.8% in 2023, due to its ability to provide wide services such as isolation & purification, miRNA cDNA synthesis, profiling, localization, & quantification, functional analysis, and others
  • Based on application, the cancer segment dominated the segment with the highest revenue share in 2023, due to high investments in cancer research adopting miRNA signatures
  • Based on end-use, the biotechnology & pharmaceutical companies segment dominate the market with the highest revenue share in 2023, due to their ability to establish collaborations and partnerships with research institutions that allow them to access cutting-edge research and collaborate on large-scale projects
  • North America dominated the global industry in 2023 owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Products & Service Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End-use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Primary Sources
  • 1.11. List of Abbreviations

Chapter 2. MicroRNA (miRNA) Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Products and Services Snapshots
  • 2.3. Application and End-use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. MicroRNA (miRNA) Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Outbreak of COVID - 19
    • 3.4.2. Recent innovation in application of miRNAs
      • 3.4.2.1. Increased adoption for use as a biomarker
      • 3.4.2.2. Therapeutic applications
    • 3.4.3. High investments in miRNA R&D initiatives for development of new diagnostic tests & therapeutics
    • 3.4.4. The success of miRNA in clinical trials
    • 3.4.5. Technological advancements to support nucleic acid studies
    • 3.4.6. Exponentially declining cost of sequencing
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost associated with microRNA kits and other products
    • 3.5.2. Challenges in handling RNA & in-house development of assays for microRNA detection
    • 3.5.3. Poor reproducibility of research and specificity of products
    • 3.5.4. Limited life science research infrastructure in emerging markets
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTLE Analysis
  • 3.7. COVID-19 Analysis

Chapter 4. Products & Services Estimates & Trend Analysis

  • 4.1. MicroRNA (miRNA) Market: Products Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Technology
      • 4.2.2.1. Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.2. Real-Time PCR
      • 4.2.2.2.1. Real-Time PCR Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.3. Microarray
      • 4.2.2.3.1. Microarray Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.4. NGS
      • 4.2.2.4.1. NGS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.5. Others
      • 4.2.2.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Workflow
      • 4.2.3.1. Workflow Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.2. Isolation & Purification
      • 4.2.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.3. miRNA cDNA Synthesis
      • 4.2.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.4. Profiling, Localization, & Qualification
      • 4.2.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.5. Functional Analysis & Others
      • 4.2.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.6. Others
      • 4.2.3.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Consumables
    • 4.3.1. Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Specimen
      • 4.3.2.1. Specimen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.2. Whole Blood
      • 4.3.2.2.1. Whole Blood Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.3. Serum
      • 4.3.2.3.1. Serum Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.4. Plasma
      • 4.3.2.4.1. Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.5. FFPE
      • 4.3.2.5.1. FFPE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.6. Fresh Frozen Tissue
      • 4.3.2.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.7. Others
      • 4.3.2.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Workflow
      • 4.3.3.1. Workflow Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.2. Isolation & Purification
      • 4.3.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.3. miRNA cDNA Synthesis
      • 4.3.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.4. Profiling, Localization, & Qualification
      • 4.3.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.5. Functional Analysis & Others
      • 4.3.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.6. Others
      • 4.3.3.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Service Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Isolation & Purification
      • 4.4.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. miRNA cDNA Synthesis
      • 4.4.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Profiling, Localization, & Qualification
      • 4.4.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Functional Analysis
      • 4.4.5.1. Functional Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Specimen
    • 4.5.1. Specimen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Whole Blood
      • 4.5.2.1. Whole Blood Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Serum
      • 4.5.3.1. Serum Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Plasma
      • 4.5.4.1. Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. FFPE
      • 4.5.5.1. FFPE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Fresh Frozen Tissue
      • 4.5.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Estimates & Trend Analysis

  • 5.1. MicroRNA (miRNA) Market: Application Movement Analysis
  • 5.2. Cancer
    • 5.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. Infectious Diseases
    • 5.3.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Immunological Disorder
    • 5.4.1. Immunological Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiovascular Disease
    • 5.5.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Neurological Disease
    • 5.6.1. Neurological Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. End-use Estimates & Trend Analysis

  • 6.1. MicroRNA (miRNA) Market: End-use Movement Analysis
  • 6.2. Biotechnology & Pharmaceutical Companies
    • 6.2.1. Biotechnology & Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Academic & Government Research Institutes
    • 6.3.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Other End-users
    • 6.4.1. Other End-users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America MicroRNA (miRNA) Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Target Disease Prevalence
      • 7.2.2.5. U.S. MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Target Disease Prevalence
      • 7.2.3.5. Canada MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Target Disease Prevalence
      • 7.3.2.5. UK MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Target Disease Prevalence
      • 7.3.3.5. Germany MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.4. Spain
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Target Disease Prevalence
      • 7.3.4.5. Spain MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Target Disease Prevalence
      • 7.3.5.5. France MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Target Disease Prevalence
      • 7.3.6.5. Italy MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Target Disease Prevalence
      • 7.3.7.5. Denmark Microrna (Mirna) Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Target Disease Prevalence
      • 7.3.8.5. Sweden MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Target Disease Prevalence
      • 7.3.9.5. Norway MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Target Disease Prevalence
      • 7.4.2.5. Japan MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Target Disease Prevalence
      • 7.4.3.5. China MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Target Disease Prevalence
      • 7.4.4.5. India MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Target Disease Prevalence
      • 7.4.5.5. South Korea MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Target Disease Prevalence
      • 7.4.6.5. Thailand MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Target Disease Prevalence
      • 7.4.7.5. Australia MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Target Disease Prevalence
      • 7.5.2.5. Brazil MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Target Disease Prevalence
      • 7.5.3.5. Mexico MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Target Disease Prevalence
      • 7.5.4.5. Argentina MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Target Disease Prevalence
      • 7.6.2.5. South Africa MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Target Disease Prevalence
      • 7.6.3.5. Saudi Arabia MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Target Disease Prevalence
      • 7.6.4.5. UAE MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Target Disease Prevalence
      • 7.6.5.5. Kuwait MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. Acquisition
    • 8.2.2. Product/Service Launch
    • 8.2.3. Partnerships/Collaborations
    • 8.2.4. Others
  • 8.3. Market Position Analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientififc, Inc
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. QIAGEN
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Horizon Discovery Group Co.
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. NanoString Technologies, Inc
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Takara Bio, Inc
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. LGC Limited
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. BioGenex
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. GeneCopoeia, Inc
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. New England Biolabs
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives